Ramipril and Brain natriuretic peptide abnormal - a phase IV clinical study of FDA data

Summary:

Brain natriuretic peptide abnormal is reported as a side effect among people who take Ramipril (ramipril), especially for people who are male, 60+ old, also take Entresto, and have Cardiac failure congestive.

The phase IV clinical study analyzes which people have Brain natriuretic peptide abnormal when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Brain natriuretic peptide abnormal?

Brain natriuretic peptide abnormal is found to be associated with 64 drugs and 88 conditions by eHealthMe. Check the latest studies of Brain natriuretic peptide abnormal.

On Jul, 16, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 16 people (0.01%) have Brain natriuretic peptide abnormal.

Could Ramipril cause Brain natriuretic peptide abnormal?

Among these 16 people:

What is the gender of people who have Brain natriuretic peptide abnormal when taking Ramipril? *

female: 26.67 %
male: 73.33 %

What is the age of people who have Brain natriuretic peptide abnormal when taking Ramipril? *

What are other drugs people take besides Ramipril? *

What are other side effects people have besides Brain natriuretic peptide abnormal? *

Oedema Peripheral (superficial swelling): 10 people, 62.50%
Cardiac Failure Chronic: 7 people, 43.75%
Fatigue (feeling of tiredness): 6 people, 37.50%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 6 people, 37.50%
Dyspnea (difficult or laboured breathing): 6 people, 37.50%
Haemoglobin Decreased: 6 people, 37.50%
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 6 people, 37.50%
Blood Creatinine Increased: 6 people, 37.50%
Blood Urea Increased: 5 people, 31.25%
Orthopnea (shortness of breath (dyspnea) when lying down): 5 people, 31.25%

What are the existing conditions these people have? *

Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 5 people, 31.25%
Cardiac Failure Congestive: 5 people, 31.25%
Pain: 3 people, 18.75%
Cardiomyopathy (weakening of the heart muscle): 2 people, 12.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 12.50%
Breast Cancer Metastatic: 2 people, 12.50%
Left Ventricular Dysfunction: 2 people, 12.50%
Cardiac Failure Chronic: 2 people, 12.50%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.25%
Cardiac Failure: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Brain natriuretic peptide abnormal?

- Check whether Brain natriuretic peptide abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Brain natriuretic peptide abnormal:

Brain natriuretic peptide abnormal (64 drugs)

Browse all the conditions that are associated with Brain natriuretic peptide abnormal:

Brain natriuretic peptide abnormal (88 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.